Titlebook: Management of Prostate Cancer; A Multidisciplinary Michel Bolla,Hendrik van Poppel Book 2017Latest edition Springer International Publishi

colony

Odyssey

個(gè)阿姨勾引你

祖先

the roles of the different therapies and active surveillance.This book, now in an extensively revised second edition, provides an exhaustive review of the state of the art in the management of prostate cancer, from screening to treatment, with emphasis on a multidisciplinary approach. The editors ar

dissolution

The Clinical Genomics of Prostate Cancer,r and contrast these unique disease states. Finally, we describe the potential utility of using molecular aberrations as prognostic and predictive biomarkers for biochemical and metastatic recurrence, as well as for targeted therapeutics for metastatic castration-resistant prostate cancer.

ANA

Diagnosis, Clinical Workup, and TNM Classification, and the lack on the risk profile of patients with localized prostate cancer in the United States which represents the current clinical presentation of patients in countries where PSA screening has been developed.

somnambulism

Book 2017Latest editionfrom screening to treatment, with emphasis on a multidisciplinary approach. The editors are very excited about the outstanding new or updated contributions from the different expert authors...The opening chapters address basic aspects including epidemiology, pathology, biology, genetics, and chemopr

狂熱語言

Epidemiology of Prostate Cancer in Europe: Patterns, Trends and Determinants,urope, with almost 400,000 cases and over 92,000 deaths. Beginning in the early to mid-1990s, the PSA-induced detection of a substantial number of early-stage prostate cancers brought about rapid increases in population-level incidence rates, initially across the higher-income countries of Northern,

ANTE

Chemoprevention,tween different geographical areas, being high in the USA and Northern Europe and low in Southeast Asia. But if one Japanese moves to the USA, the risk of PCa increases (Breslow et al. Int J Cancer 20:680, 1977). These results indicate there are exogenous factors that affect the risk of PCa, such as

projectile

Individual and Population-Based Screening, United States. In some Asian countries, PCa incidence has been rising rapidly over the last 20 years. The European Randomized Study of Screening for prostate cancer shows that prostate-specific antigen-based screening reduces the prostate cancer mortality by 21 % after 13 years of follow-up. Howeve